| Disease Name |
Medulloblastoma |
| Nocoding RNA Name |
hsa-miR-22 |
| Expression Pattern |
down-regulated |
| Species |
Homo sapiens |
| Detection Methods |
Quantitative RT-PCR,fluorescence in situhybridization,Western Blot,Luciferase Reporter Assay etc. |
| Target |
N/A |
| Tissue |
medulloblastoma cell lines |
| Treatment |
N/A
|
| PubMed ID |
24576181 |
| Year |
2014 |
| Detail Description |
Quantitative RT-PCR revealed significantly lower expression of miR-22 in 19/27(70%)medulloblastomas, D341,DAOY, ONS-76 medulloblastoma cell lines, compared to normal cerebellum. Quantitative RT-PCR revealed PAPST1 up-regulation in 18/27(67%)medulloblastomas. In addition, a luciferase reporter assay in ONS-76 and DAOY cells suggested that miR-22 directly targets the PAPST1 gene, and lentivirus-mediated knock-down of PAPST1 suppressed proliferation of DAOY and ONS-76 medulloblastoma cells. |
|